Company: BIVIW
Filing Date: 2025-10-06
Form Type: POS AM
Source: 0001520138-25-000294
Chunk: 37

Company: BIOVIE INC.
Filing Date: 2025-10-06
Form: POS AM
Chunk 37
---
 per pre-funded warrant, together with warrants to purchase up to 105,000 shares of Common Stock.

In connection to the offering, the Company issued
warrants to the placement agent, exercisable to purchase 10,500 shares of Common Stock, representing 5% of the securities purchased at
the closing of the offering, for an aggregate purchase price of $100.00, at an exercise price of $125.00 per share, which is equal to
125% of the public offering price. The placement agent warrants are exercisable from 180 days following the date of issuance in accordance
with Rule 5110(g)(8)(A) of FINRA and will expire five years following the date of issuance.

The holders of the placement agent warrants may exercise
the placement agent warrants by making a cash payment equal to the exercise price multiplied by the quantity of shares. The holders of
the placement agent warrants may also exercise the placement agent warrants on a cashless or “net issuance” basis by receiving
a net number of shares calculated pursuant to the formula set forth in the placement agent warrants. The placement agent warrants are
subject to anti-dilution adjustments for stock dividends, stock splits, and reverse stock splits. Pursuant to the terms of the placement
agent warrants, the holders are entitled to piggyback registration rights if the Company proposes to file a new registration statement
under the Securities Act, subject to certain limitations.

Placement Agent II Warrants Issued in Connection with Offering on September 23, 2024

On September 23, 2024, the Company entered into a
placement agency agreement with ThinkEquity LLC, as the placement agent, in connection with the issuance and sale of up to 196,080 shares
of Common Stock, at a public offering price of $15.30 per share and/or pre-funded warrants to purchase shares of Common Stock, at a public
offering price of $15.30 per pre-funded warrant, together with warrants to purchase up to 196,080 shares of Common Stock.

In connection to the offering, the Company issued
warrants to the placement agent, exercisable to purchase 9,142 shares of Common Stock, representing 5% of the securities purchased at
the closing of the offering, for an aggregate purchase price of $100.00, at an exercise price of $19.125 per share, which is equal to
125% of the public offering price. The placement agent warrants are exercisable from 180 days following